Daniel A Monti
Affiliation: Thomas Jefferson University
- Changes in cerebral blood flow and anxiety associated with an 8-week mindfulness programme in women with breast cancerDaniel A Monti
Jefferson Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
Stress Health 28:397-407. 2012..The results demonstrate that the MBAT programme was associated with significant changes in CBF, which correlated with decreased anxiety over an 8-week period...
- Short term correlates of the Neuro Emotional Technique for cancer-related traumatic stress symptoms: a pilot case seriesDaniel A Monti
Department of Psychiatry and Human Behavior, Thomas Jefferson University and Hospital, 111 S 11th Street, Philadelphia, PA 19107, USA
J Cancer Surviv 1:161-6. 2007..Treatment options for the hallmark symptoms of traumatic stress--unpleasant, intrusive thoughts and avoidant behaviors--have not been well investigated for the cancer survivorship population...
- Potential role of mind-body therapies in cancer survivorshipDaniel A Monti
Myrna Brind Center of Integrative Medicine, Thomas Jefferson University and Hospital, Philadelphia, Pennsylvania 19107, USA
Cancer 112:2607-16. 2008..A theoretical foundation by which such therapies provide benefit is presented, with particular emphasis on self-regulation...
- Psychosocial benefits of a novel mindfulness intervention versus standard support in distressed women with breast cancerDaniel A Monti
Jefferson Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, PA, USA
Psychooncology 22:2565-75. 2013....
- Managing cancer pain with nonpharmacologic and complementary therapiesLynette A Menefee Pujol
Jefferson Pain Center, Department of Anesthesiology, Jefferson Medical College, 834 Chestnut St, Philadelphia, PA 19107 5127, USA
J Am Osteopath Assoc 107:ES15-21. 2007..This review updates an article published in November 2005. An anecdotal case study has been added to illustrate incorporation of nonpharmacologic and complementary therapies in the treatment of a patient with cancer-related pain...
- Complementary medicine in chronic cancer careDaniel A Monti
Department of Psychiatry and Human Behavior, Jefferson Medical College, Philadelphia, PA 19107, USA
Semin Oncol 32:225-31. 2005....
- A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancerDaniel A Monti
Thomas Jefferson University, Philadelphia, PA 19107, USA
Psychooncology 15:363-73. 2006..This investigation of MBAT provides initial encouraging data that support a possible future role for the intervention as a psychosocial treatment option for cancer patients...
- Nonpharmacologic and complementary approaches to cancer pain managementLynette A Menefee
Jefferson Medical College, Department of Anesthsiology, Jefferson Pain Center, 834 Chestnut St, Philadelphia, PA 19107 5127, USA
J Am Osteopath Assoc 105:S15-20. 2005..It focuses on those modalities that have empirical support or promising preliminary evidence, with the goal of familiarizing physicians with treatment modalities that may complement regular oncologic care...
- Meditation and neurodegenerative diseasesAndrew B Newberg
Jefferson Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
Ann N Y Acad Sci 1307:112-23. 2014..This review discusses the current data on meditation, memory, and attention, and the potential applications of meditation techniques in patients with neurodegenerative diseases. ..
- Current evidence regarding the management of mood and anxiety disorders using complementary and alternative medicineAnthony J Bazzan
Thomas Jefferson University Integrative Medicine, Philadelphia, PA, USA
Expert Rev Neurother 14:411-23. 2014..There are a growing number of research studies on the effectiveness of CAM interventions in mood and anxiety disorders, and this review evaluates and critiques such data. ..
- Complementary and alternative medicine therapies in mood disordersAleeze S Moss
Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
Expert Rev Neurother 11:1049-56. 2011..There is an increasing number of research studies on CAM intervention in mood disorders, and this article critiques such data and attempts to provide a clinical perspective within which these CAM interventions might be considered...
- N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line DataDaniel A Monti
Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, PA, United States of America
PLoS ONE 11:e0157602. 2016..The purpose of this study was to assess the biological and clinical effects of n-acetyl-cysteine (NAC) in Parkinson's disease (PD)...
- Positron emission tomography in psychiatric disordersAndrew B Newberg
Department of Emergency Medicine and Radiology, Thomas Jefferson University, 1015 Chestnut Street, Suite 412, Philadelphia, PA 19107, USA
Ann N Y Acad Sci 1228:E13-25. 2011....
- Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicityLauren Rouleau
MitoCare Center, Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA
Free Radic Biol Med 95:308-22. 2016....
- Selectively starving cancer cells through dietary manipulation: methods and clinical implicationsBrittany A Simone
Department of Radiation Oncology, Kimmel Cancer Center and Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
Future Oncol 9:959-76. 2013..This article will delineate three commonly used methods of dietary manipulation to assess the potential of each as a regimen for cancer therapy. ..
- Practical geriatrics: depression, cognition, and anxiety among postmenopausal women with breast cancerDaniel A Monti
Jefferson Myrna Brind Center for Integrative Medicine at Thomas Jefferson University, 111 South 11th Street, Suite 6215, Gibbon Building, Philadelphia, Pennsylvania 19107, USA
Psychiatr Serv 56:1353-5. 2005
- Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancerDaniel A Monti
Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
PLoS ONE 7:e29794. 2012..Preclinical data support further investigation of ascorbic acid in pancreatic cancer. There are currently insufficient safety data in human subjects, particularly when ascorbic acid is combined with chemotherapy...